Search research articles
Contact Us
Filters
Showing results (81-90 of 395) with videos related to
Page
of 40
Sort By:
Pain Practice : the Official Journal of World Institute of Pain
|
June 18, 2021
Decreased pain sensitivity and alterations of cerebrospinal fluid and plasma inflammatory mediators after total hip arthroplasty in patients with disabling osteoarthritis
Martin F Bjurström, Mikael Bodelsson, Michael R Irwin, et al.
Molecular and Cellular Neurosciences
|
December 12, 2018
Biomarkers for tau pathology
Michael Schöll, Anne Maass, Niklas Mattsson, et al.
Alzheimer'S Research & Therapy
|
March 28, 2021
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Claudia Cicognola, Shorena Janelidze, Joakim Hertze, et al.
Journal of Alzheimer'S Disease : JAD
|
August 16, 2014
Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease
R Scott Mackin, Philip Insel, Jing Zhang, et al.
European Journal of Neurology
|
October 27, 2025
Diagnostic and Prognostic Value of Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
Kazuki Obara, Daisuke Ito, Christer Nilsson, et al.
Plos One
|
January 7, 2014
Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease
Niklas Mattsson, Philip Insel, Duygu Tosun, et al.
JAMA Neurology
|
March 17, 2015
Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls
Niklas Mattsson, Philip S Insel, Michael Donohue, et al.
Neuromolecular Medicine
|
February 22, 2012
Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease
Christoffer Rosén, Ulf Andreasson, Niklas Mattsson, et al.
Neurology
|
September 11, 2015
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
Sebastian Palmqvist, Henrik Zetterberg, Niklas Mattsson, et al.
Neurology
|
July 29, 2018
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
Shorena Janelidze, Niklas Mattsson, Erik Stomrud, et al.
Page
of 40
Search research articles
Search
Showing results (81-90 of 395) with videos related to
Sort By:
Page
of 40
Pain Practice : the Official Journal of World Institute of Pain
|
June 18, 2021
Decreased pain sensitivity and alterations of cerebrospinal fluid and plasma inflammatory mediators after total hip arthroplasty in patients with disabling osteoarthritis
Martin F Bjurström, Mikael Bodelsson, Michael R Irwin, et al.
Molecular and Cellular Neurosciences
|
December 12, 2018
Biomarkers for tau pathology
Michael Schöll, Anne Maass, Niklas Mattsson, et al.
Alzheimer'S Research & Therapy
|
March 28, 2021
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Claudia Cicognola, Shorena Janelidze, Joakim Hertze, et al.
Journal of Alzheimer'S Disease : JAD
|
August 16, 2014
Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease
R Scott Mackin, Philip Insel, Jing Zhang, et al.
European Journal of Neurology
|
October 27, 2025
Diagnostic and Prognostic Value of Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
Kazuki Obara, Daisuke Ito, Christer Nilsson, et al.
Plos One
|
January 7, 2014
Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease
Niklas Mattsson, Philip Insel, Duygu Tosun, et al.
JAMA Neurology
|
March 17, 2015
Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls
Niklas Mattsson, Philip S Insel, Michael Donohue, et al.
Neuromolecular Medicine
|
February 22, 2012
Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease
Christoffer Rosén, Ulf Andreasson, Niklas Mattsson, et al.
Neurology
|
September 11, 2015
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
Sebastian Palmqvist, Henrik Zetterberg, Niklas Mattsson, et al.
Neurology
|
July 29, 2018
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
Shorena Janelidze, Niklas Mattsson, Erik Stomrud, et al.
Page
of 40